Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1β/IL-1RI complex

被引:62
|
作者
Casadio, R
Frigimelica, E
Bossù, P
Neumann, D
Martin, MU
Tagliabue, A
Boraschi, D
机构
[1] Natl Res Council, IMD, Immunobiol Lab, I-56124 Pisa, Italy
[2] ALTA Srl, I-53035 Monteriggioni, Italy
[3] Med Hsch Hannover, D-30623 Hannover, Germany
[4] Dompe SpA, I-67100 Laquila, Italy
[5] Univ Bologna, Lab Biocomp, Bologna, Italy
关键词
interleukin; 1; receptor chain; accessory protein; molecular modeling;
D O I
10.1016/S0014-5793(01)02515-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A preliminary model has been calculated for the activating interaction of the interleukin 1 receptor (IL-1R) accessory protein IL-1RAcP with the ligand/receptor complex IL-I beta /IL-1R(1). First, IL-1RAcP was modeled on the crystal structure of IL-1R(1) bound to IL-1 beta. Then, the IL-1RAcP model was docked using specific programs to the crystal structure of the IL-1 beta /IL-1R(1) complex. Two types Of models were predicted, with comparable probability, Experimental data obtained with the use of IL-1 beta peptides and antibodies, and with mutated IL-1 beta proteins, support the BACK model, in which IL-1RAcP establishes contacts with the bark of IL-1R(1) wrapped around IL-1 beta. (C) 2001 Federation of European Biochemical Societies, Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:65 / 68
页数:4
相关论文
共 50 条
  • [1] Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP)
    Yilmaz-Elis, A. Seda
    Aartsma-Rus, Annemieke
    't Hoen, Peter A. C.
    Safdar, Huma
    Breukel, Cor
    van Vlijmen, Bart J. M.
    van Deutekom, Judith
    de Kimpe, Sjef
    van Ommen, Gert-Jan
    Verbeek, J. Sjef
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2013, 2 : e66
  • [2] Type I IL-1 Receptor (IL-1RI) as Potential New Therapeutic Target for Bronchial Asthma
    Lee, Jyh-Hong
    Wang, Li-Chieh
    Yu, Hsin-Hui
    Lin, Yu-Tsan
    Yang, Yao-Hsu
    Chiang, Bor-Luen
    MEDIATORS OF INFLAMMATION, 2010, 2010
  • [3] Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors-Insight into Heterotrimeric IL-1 Signaling Complexes
    Lingel, Andreas
    Weiss, Thomas M.
    Niebuhr, Marc
    Pan, Borlan
    Appleton, Brent A.
    Wiesmann, Christian
    Bazan, J. Fernando
    Fairbrother, Wayne J.
    STRUCTURE, 2009, 17 (10) : 1398 - 1410
  • [4] Complex effects of IL1A polymorphism and calpain inhibitors on interleukin 1α (IL-1α) mRNA levels and secretion of IL-1α protein
    Lee, S.
    Temple, S.
    Roberts, S.
    Price, P.
    TISSUE ANTIGENS, 2008, 72 (01): : 67 - 71
  • [5] PHARMACOLOGICAL EXPLOITATION OF IL-1 AND IL-1 RELATED MOLECULES
    TAGLIABUE, A
    BOSSU, P
    MAURIZI, G
    COLAGRANDE, A
    BORASCHI, D
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1994, 7 (03) : 235 - 239
  • [6] SPECIES-SPECIFIC BINDING OF IL-1, BUT NOT THE IL-1 RECEPTOR ANTAGONIST, BY FIBROBLASTS
    LEDERER, JA
    CZUPRYNSKI, CJ
    CYTOKINE, 1994, 6 (02) : 154 - 161
  • [7] Characterization of IL-1β and two types of IL-1 receptors in miiuy croaker and evolution analysis of IL-1 family
    Yang, Qiong
    Chu, Qing
    Zhao, Xueyan
    Xu, Tianjun
    FISH & SHELLFISH IMMUNOLOGY, 2017, 63 : 165 - 172
  • [8] The Efficacy of an IL-1α Vaccine Depends on IL-1RI Availability and Concomitant Myeloid-derived Suppressor Cell Reduction
    Weiss, Tobias
    Vitacolonna, Mario
    Zoeller, Margot
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (06) : 552 - 564
  • [9] Association of IL-1β and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers
    Joos, L
    McIntyre, L
    Ruan, J
    Connett, JE
    Anthonisen, NR
    Weir, TD
    Paré, PD
    Sandford, AJ
    THORAX, 2001, 56 (11) : 863 - 866
  • [10] Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis
    Wilkinson, RJ
    Patel, P
    Llewelyn, M
    Hirsch, CS
    Pasvol, G
    Snounou, G
    Davidson, RN
    Toossi, Z
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) : 1863 - 1873